Qure.ai announces world’s first AI-powered paediatric TB screening tool to extend proactive reach from birth to 15 years
qXR from Qure.ai is the first AI-enabled chest X-ray tool to receive regulatory clearance, earning CE Class IIb certification for children aged 0–3 years and complementing its existing capabilities for children up to 15 years, effectively covering the entire childhood spectrum. With this clearance, it can now help health systems and national TB programmes identify children at the highest risk of active TB even in the absence of symptoms.
Dr Shibu Vijayan, Chief Medical Officer, Global Health at Qure.ai, said, "Achieving CE clearance for AI-enabled Chest X-ray screening in children is a major step forward in the fight against paediatric TB. The youngest children have long been the hardest to reach and the most vulnerable. With this tool, we are proud to equip healthcare systems worldwide with a scalable, reliable way to detect TB early, prioritise care, and ultimately save lives."
Additionally, Qure has implemented the Treatment Decision Algorithm A (TDA), as outlined in the WHO Consolidated Guidelines on Tuberculosis: Module 5 – Management of Tuberculosis in Children and Adolescents (2022), within the care coordination platform- qTrack from Qure.ai. This functionality enables structured data entry and automated computation of algorithmic parameters to facilitate clinical diagnosis of tuberculosis in children who are bacteriologically negative or unable to undergo microbiological testing.
